Ticker Attention Investors: Note: The depositories (CDSL/NSDL), in coordination with SEBI, have upgraded their investor mobile applications to provide a consolidated view of investors’ holdings in securities markets. CDSL: MyEasiApp | NSDL: Speede App Beware of fraudulent Calls, SMS, Emails, WhatsApp & Telegram messages assuring high returns and / or enticing you to invest money in the name of Aditya Birla Money by installing fake App from spurious links. You can download our Elevate App only from Google Play Store or Apple App Store or login to Elevate Web portal. Click Here to know more.

Aditya Birla Money Limited

Aditya Birla Money Limited

Lactose (India) Ltd

Symbol : Not Listed | BSE Code : 524202 | Sector : PHARMACEUTICALS - INDIAN - BULK DRUGS

Market Cap (₹ Cr.)

Today’s High / Low
52 Week High / Low
83.92-0.24 (-0.29%)
02-Apr-2026 | 12:00
Loading

Market Cap (₹ Cr.)

105.65
Today’s High / Low
86.17
82.52
52 Week High / Low
136.70
76.01

Turnover (₹ Cr.)

82,717,186,200.00
Today’s High / Low
51,993
50,172.00

Turnover (₹ Cr.)

0.00
Today’s High / Low
0
0.00
OVERVIEW
  • Open
  • Prev. Close
  • High
  • Low
  • Market Cap (₹ Cr.)
  • 52 Week High
  • 52 Week Low
  • Traded Volume (Lacs)
  • Traded Value (Cr)
  • Dividend Yield
  • 0.00
  • Face Value
  • 10.00
  • EPS
  • 3.84
  • P/E
  • 21.85
  • Beta (1 year)
  • 1.02
OVERVIEW
  • Open
  • 83.00
  • Prev. Close
  • 84.16
  • High
  • 86.17
  • Low
  • 82.52
  • Market Cap (₹ Cr.)
  • 105.65
  • 52 Week High
  • 136.70
  • 52 Week Low
  • 76.01
  • Traded Volume (Lacs)
  • 3,358
  • Traded Value (Cr)
  • Dividend Yield
  • 0.00
  • Face Value
  • 10.00
  • EPS
  • 3.84
  • P/E
  • 21.85
  • Beta (1 year)
OVERVIEW
  • Open
  • 50,760.00
  • Prev. Close
  • 51,784.60
  • High
  • 51,993
  • Low
  • 50,172.00
  • Strike Price
  • 0.00
  • Open Interest(Nos.)
  • 2,472,210.00
  • OI Change %
  • 3.30
  • Volume(Lacs)
  • 3.30
  • Lot Size
  • 30.00
  • Average Price
  • 50,944.43
  • OI Difference
  • 79,080.00
  • Previous OI
  • 2,393,130.00
OVERVIEW
  • Open
  • 0.00
  • Prev. Close
  • 1,940.00
  • High
  • 0
  • Low
  • 0.00
  • Strike Price
  • 24,950.00
  • Open Interest(Nos.)
  • 2,860.00
  • OI Change %
  • 0.00
  • Volume(Lacs)
  • 0.00
  • Lot Size
  • 65.00
  • Average Price
  • 0.00
  • OI Difference
  • 0.00
  • Previous OI
  • 2,860.00
LAST 5 DAYS

1 YEAR RETURN - UNDERPERFORMED THE SENSEX BY 9.23%

  • 05/04/2026 BSE
    -0.24(-0.29)
    Close Price: ₹ 83.92
    Volume: 3,358.00

    02-Apr-2026
  • 05/04/2026 BSE
    3.75(4.66)
    Close Price: ₹ 84.16
    Volume: 9,766.00

    01-Apr-2026
  • 05/04/2026 BSE
    2.22(2.84)
    Close Price: ₹ 80.41
    Volume: 10,566.00

    30-Mar-2026
  • 05/04/2026 BSE
    -6.57(-7.75)
    Close Price: ₹ 78.19
    Volume: 21,264.00

    27-Mar-2026
  • 05/04/2026 BSE
    0.26(0.31)
    Close Price: ₹ 84.76
    Volume: 9,098.00

    25-Mar-2026

1 YEAR RETURN - UNDERPERFORMED THE SENSEX BY 9.23%

  • Stock Absolute
  • 7.33
  • -8.91
  • -13.54
  • 99.81
  • 216.68
  • Returns
  • 1W
  • 1M
  • 1Y
  • 3Y
  • 5Y
  • Sensex Absolute
  • -0.36
  • -8.62
  • -4.30
  • 24.05
  • 49.15
NEWS

Lactose (India) to conduct EGM

27-Feb-2026

No Data Available

Lactose (India) announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 28 March 2026.

27
Feb

Lactose (India) to conduct EGM



13
Feb

Lactose (India) standalone net profit rises 140.91% in the December 2025 quarter



10
Feb

Lactose (India) to declare Quarterly Results



FINANCIAL DATA

In Cr.

Mar 2025Mar 2024Mar 2023
SOURCES OF FUNDS :   
Share Capital 12.5912.5912.59
Reserves Total 39.6334.5127.97
Equity Share Warrants6.530.000.00
Equity Application Money0.000.000.00
Read More
Mar 2025Mar 2024Mar 2023
INCOME :   
Sales Turnover 116.40113.8965.80
Excise Duty0.000.000.00
Net Sales116.40113.8965.80
Other Income 1.451.120.72
Read More
ParticularsDec 2025Sep 2025Jun 2025
Gross Sales 36.7741.1839.58
Excise Duty 000
Net Sales 36.7741.1839.58
Other Operating Income 000
Other Income  0.630.370.41
Read More
Category No. Of Shares Percentage (%)
Total Foreign 38239 0.30
Total Institutions 77920 0.62
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 804461 6.39
Total Promoters 6753426 53.65
Total Public & others 4,914,954.00 39.04
Total 100.00 100.00
Read More
CORPORATE ACTIONS
Record Date Ex-Bonus Date Ratio
nodata
No Data Available!!!
Read More
Record Date Split Date Face Value Before Face Value After
nodata
No Data Available!!!
Read More
ANNOUNCEMENT DATE EX DIVIDEND DATE DIVIDEND (%) DIVIDEND TYPE
nodata
No Data Available!!!
Read More
PREMIUM (₹) RATIO RECORD DATE EX RIGHTS DATE
nodata
No Data Available!!!
Read More
Read More
FROM DATE EX TO DATE AGENDA
28-03-2026 NA Pursuant to the NCLT order, we...
22-03-2026 28-03-2026 Pursuant to the NCLT order, w...
13-02-2026 NA Lactose India Ltdhas informed ...
17-12-2025 NA SST PRIVATE FAMILY TRUST
17-12-2025 NA Madhusha Lifecare Private Limi...
COMPANY INFO

Lactose (India) Limited was incorporated on March 1991 as a Public Limited Company in Vadodara district of Gujarat. Company engages in the manufacturing and trading of pharmaceutical products. It edible and pharmaceutical grade lactose, as an ingredient used in pharmaceutical products, as well as in dairy, food, confectionery, and beverage industries. It also manufactures dairy whitener, dairy calcium, whey powder, casein, caseinate, butter, and ghee. Further, it engage in the contract manufacture of pharmaceutical products.

The company is having their manufacturing facilities located at Vadodara in Gujarat. This state of art manufacturing facilities for the manufacture of pharmaceutical formulations is in compliance with all international standards. The manufacturing facilities include wet granulation, Fluid bed drying, compaction, blending and coating facilities with the latest technology equipments. The company is well backed up by its excellent network of indenting agents in India i.e. Mumbai, Delhi, Chennai, Bangalore, Calcutta, Hyderabad and Ahmedabad.

The company set up a project to manufacture lactose IP/BP grade, an import substitute, with an installed capacity of 465 TPA at an estimated cost of Rs 4.5 crore. The unit was commissioned by Alfa Laval, Pune, a subsidiary of Alfa Laval, Sweden. In January 1994, the company commenced commercial production of Lactose.

In the year 1994, the company undertook an expansion and forward integration programme involving the capacity expansion of lactose from 465 tpa to 1500 tpa. They also set up of a pharmaceutical formulation plant with three sections, namely capsule section, tablet section and indictable section.

During the year 1995-96, the company started processing sweetened condenced milk for domestic supply and acid casein for exports. They had started the job work of condensed milk casein powder.

During the year 2004-05, the company streamlined their pharmaceutical plant and entered into long-t

Read More
Get Free Demat Account
Captcha Image